• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIATORR® TIPS ENDOPROSTHESIS; SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIATORR® TIPS ENDOPROSTHESIS; SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS Back to Search Results
Device Problem Complete Blockage (1094)
Patient Problem Obstruction/Occlusion (2422)
Event Date 11/30/2021
Event Type  Injury  
Manufacturer Narrative
Literature citation: keshava sn, moses v, sharma a, et al.Technical and medium-term clinical outcomes of transjugular intrahepatic portosystemic shunt with fluoroscopy and additional transabdominal ultrasound guidance.Indian j radiol imaging 2021; 31(04): 858-866 doi: 10.1055/s-0041-1735928 the gore® viatorr® tips endoprosthesis instructions for use list shunt stenosis or occlusion as adverse events that may occur and / or require intervention due to the tips procedure or underlying liver disease.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
This information was received through literature article "technical and medium-term clinical outcomes of transjugular intrahepatic portosystemic shunt with fluoroscopy and additional trans-abdominal ultrasound guidance" published online 30 november 2021 in the indian journal of radiology imaging.The article reports that occlusion of the stents was noted in 12 patients within 1 month of tips.Of the 12 stents placed, three were viatorr stent-graft (gore, flagstaff, arizona, united states), seven were niti-s (taewoong medical, seoul, south korea), and two were bare metal stents.Of the 12 patients who developed occlusion of stent within 1 month of tips, the occlusion was tackled successfully in 10 patients with angioplasty of the stent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIATORR® TIPS ENDOPROSTHESIS
Type of Device
SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL PHOENIX 1 B/P
32360 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
marci stewart
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key15452337
MDR Text Key300213640
Report Number3007284313-2022-02120
Device Sequence Number1
Product Code MIR
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P040027
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 09/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/19/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/08/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age37 YR
Patient SexMale
-
-